Blood Biomarkers and Abdominal Aortic Aneurysm

Biomarker Profiling in Abdominal Aortic Aneurysm Patients

Recruiting Observational Study
Abdominal Aortic Aneurysm
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
440 (estimated)
Sponsor
Erasmus Medical Center · Other
Who this trial is looking for

This trial is looking for adults with abdominal aortic aneurysm (AAA) to study how blood markers relate to the growth of their aneurysm. Participants will either be monitored over time or have a specific procedure to treat their condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old
  • I have been diagnosed with AAA that is 40mm or larger
  • I am being monitored for my AAA
  • I plan to undergo EVAR for my AAA
  • I have had EVAR in the past for my AAA

You may not be able to join if

  • I have an isolated iliac artery aneurysm
  • I have a thoracic aneurysm
  • I have a condition that limits my life expectancy to 1 year or less
  • I am dependent on dialysis
  • I am a woman of childbearing age
  • I have a language barrier
  • I am unlikely to attend all scheduled follow-ups

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The BIOMArCS-AAA study aims to investigate the associations of (temporal patterns of) blood biomarkers with aneurysm growth in patients with abdominal aortic aneurysm (AAA), with particular attention to biomarkers that have demonstrated prognostic value for adverse disease outcomes in coronary artery disease and biomarkers for the main genetic pathways associated with AAA.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age of 18 years or older * Capable of understanding and signing informed consent AND one of the following 1. Diagnosis of AAA, with a diameter ≥40mm, based on any imaging technique and treated by watchful waiting strategy (Prospective longitudinal study, Arm 1 watchful wait…
Contacts

Isabella Kardys, MD, PhD

+31650032051

i.kardys@erasmusmc.nl

CONTACT

Eric Boersma, MSc, PhD

+31107031814

h.boersma@erasmusmc.nl

CONTACT